青斑血管炎的研究进展

Abstract

Abstract:

Jing Ke, Feng Suying Department of Dermatology, Hospital of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Nanjing 210042, China Corresponding author: Feng Suying, Email: fengsuying@medmail.com.cn 【Abstract】 Livedoid vasculitis is a kind of skin disease caused by local vascular occlusion. It mainly manifests as erythematous and purpuric maculas or papules on the legs and ankles, which may progress into intensely painful ulcers and heal leaving porcelain-white atrophic scars called "atrophie blanche". Histopathologically, inflammatory response is weak or absent in local lesions of livedoid vasculitis, hence, it is commonly considered to be related to local thrombosis and other autoimmune diseases. Now, it is mainly managed with anticoagulation-based comprehensive treatment in clinic.

CLC Number:

R758.69

References ［24］

［1］	Gonzalez⁃Santiago TM, Davis MD. Update of management of connective tissue diseases: livedoid vasculopathy［J］. Dermatol Ther, 2012, 25（1529⁃8019 （Electronic）: 183⁃194.
［2］	Criado PR, Rivitti Ea Fau Sotto MN, Sotto Mn Fau Valente NYS, et al. Livedoid vasculopathy: an intringuing cutaneous disease［J］. Anais Brasileiros de Dermatologia, 2011, 86（1806⁃4841 （Electronic）: 961⁃977.
［3］	Browning CE, Callen JP. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia［J］. Arch Dermatol, 2006, 142（0003⁃987X （Print）: 75⁃78.
［4］	Di Giacomo TB, Hussein Tp Fau Souza DG, Souza Dg Fau Criado PR, et al. Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs: a prospective study［J］. J Eur Acad Dermatol Venereol, 2010, 24（1468⁃3083 （Electronic）: 1340⁃1346.
［5］	Khenifer S, Thomas L, Balme B, et al. Livedoid vasculopathy: thrombotic or inflammatory disease?［J］. Clin Exp Dermatol, 2010, 35（7）: 693⁃698. DOI: 10.1111/j.1365⁃2230.2009.03732.x.
［6］	Khenifer S, Thomas L, Balme B, et al. Livedoid vasculiltis associated with a double heterozygous Factor V Leiden and prothrombin G20210A gene mutations［J］. Clin Exp Dermatol, 2009, 34（8）: e811⁃e813. DOI: 10.1111/j.1365⁃2230.2009.03541.x.
［7］	袁建国, 蔡在胜, 刘睿, 等. 47例青斑血管炎临床分析［J］. 中华皮肤科杂志, 2013, 46（9）: 630⁃632. DOI: 10.3760/cma.j.issn.0412⁃4030.2013.09.006.
	Yuan JG, Cai ZS, Liu R, et al. Clinical analysis of 47 cases of livdo vasculits［J］. Chin J Dermatol, 2013, 46（9）: 630⁃632. DOI: 10.3760/cma.j.issn.0412⁃4030.2013.09.006.
［8］	Feng SY, Jin PY, Shao CG. The significance of anticardiolipin antibody and immunologic abnormality in livedoid vasculitis［J］. Int J Dermatol, 2011, 50（1）: 21⁃23. DOI: 10.1111/j.1365⁃4632.2010.04569.x.
［9］	McCalmont CS, McCalmont TH, Jorizzo JL, et al. Livedo vasculitis: vasculitis or thrombotic vasculopathy?［J］. Clin Exp Dermatol, 1992, 17（1）: 4⁃8.
［10］	Criado PR, Rivitti EA, Sotto MN, et al. Livedoid vasculopathy as a coagulation disorder［J］. Autoimmun Rev, 2011, 10（6）: 353⁃360. DOI: 10.1016/j.autrev.2010.11.008.
［11］	Yong AA, Tan AW, Giam YC, et al. Livedoid vasculopathy and its association with factor V Leiden mutation［J］. Singapore Med J, 2012, 53（12）: e258⁃e260.
［12］	Boyvat A, Kundakci N, Babikir MO, et al. Livedoid vasculopathy associated with heterozygous protein C deficiency［J］. Br J Dermatol, 2000, 143（4）: 840⁃842.
［13］	Baccard M, Vignon⁃Pennamen MD, Janier M, et al. Livedo vasculitis with protein C system deficiency［J］. Arch Dermatol, 1992, 128（10）: 1410⁃1411.
［14］	Hairston BR, Davis MD, Pittelkow MR, et al. Livedoid vasculo⁃pathy: further evidence for procoagulant pathogenesis［J］. Arch Dermatol, 2006, 142（11）: 1413⁃1418. DOI: 10.1001/archderm.142.11.1413.
［15］	Agirbasli M, Eren M, Eren F, et al. Enhanced functional stability of plasminogen activator inhibitor⁃1 in patients with livedoid vasculopathy［J］. J Thromb Thrombolysis, 2011, 32（1）: 59⁃63. DOI: 10.1007/s11239⁃011⁃0556⁃y.
［16］	Castillo⁃Martinez C, Moncada B, Valdes⁃Rodriguez R, et al. Livedoid vasculopathy （LV） associated with sticky platelets syndrome type 3 （SPS type 3） and enhanced activity of plasmi⁃nogen activator inhibitor （PAI⁃1） anomalies［J］. Int J Dermatol, 2014, 53（12）: 1495⁃1497. DOI: 10.1111/j.1365⁃4632.2012. 05786.x.
［17］	Acland KM, Darvay A, Wakelin SH, et al. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome?［J］. Br J Dermatol, 1999, 140（1）: 131⁃135.
［18］	Chen KR, Toyohara A, Suzuki A, et al. Clinical and histo⁃pathological spectrum of cutaneous vasculitis in rheumatoid arthritis［J］. Br J Dermatol, 2002, 147（5）: 905⁃913.
［19］	Klein KL, Pittelkow MR. Tissue plasminogen activator for treatment of livedoid vasculitis［J］. Mayo Clin Proc, 1992, 67（10）: 923⁃933.
［20］	梁晶, 宋泽蓉, 李红艳, 等. 白色萎缩6例误诊分析［J］. 实用医学杂志, 2012（12）: 2083⁃2084. DOI: 10.3969/j.issn.1006⁃5725. 2012.12.060.
	Liang J, Song ZR, Li HY, et al. Analysis of six misdiagnosed cases of white atrophy［J］. J Pract Med, 2012（12）: 2083⁃2084. DOI: 10.3969/j.issn.1006⁃5725.2012.12.060.
［21］	Callen JP. Livedoid vasculopathy: what it is and how the patient should be evaluated and treated［J］. Arch Dermatol, 2006, 142（11）:1481⁃1482. DOI: 10.1001/archderm.142.11.1481.
［22］	Criado PR, de Souza Espinel ID, Valentef NS, et al. Livedoid vasculopathy and high levels of lipoprotein （a）: response to danazol［J］. Dermatol Ther, 2015, 28（4）: 248⁃253. DOI: 10.1111/dth.12225.
［23］	Kerk N, Drabik A, Luger TA, et al. Rivaroxaban prevents painful cutaneous infarctions in livedoid vasculopathy［J］. Br J Dermatol, 2013, 168（4）: 898⁃899. DOI: 10.1111/bjd.12100.
［24］	Mofarrah R, Aberer W, Aberer E. Treatment of livedoid vasculo⁃pathy with alprostadil （PGE⁃1）: case report and review of published literature［J］. J Eur Acad Dermatol Venereol, 2013, 27（2）: e252⁃e254. DOI: 10.1111/j.1468⁃3083.2012.04480.x.

[1]	. Ultrahistopathological features of six cases of symmetrical acrokeratoderma under transmission electron microscope [J]. Chinese Journal of Dermatology, 2018, 51(2): 131-135.
[2]	Zhu Jianing, Xue Jing. Association of extracellular vesicles with systemic sclerosis and their application [J]. Chinese Journal of Dermatology, 2017, 50(12): 933-935.
[3]	. Clinical analysis of eight cases of adult-onset Still′s disease [J]. Chinese Journal of Dermatology, 2017, 50(9): 654-657.
[4]	Shu ZHANG Qin-Tian ZHOU. A case of cutaneous ciliated cyst of the nose in a postmenopausal woman [J]. Chinese Journal of Dermatology, 2016, 49(9): 663-663.
[5]	. Effects of chidamide combined with curcumin on human cutaneous T-cell lymphoma cell line Hut78 and their molecular mechanisms [J]. Chinese Journal of Dermatology, 2016, 49(2): 112-118.
[6]	. A case of pachydermoperiostosis caused by a deletion mutation in the HPGD gene [J]. Chinese Journal of Dermatology, 2016, 49(1): 47-49.
[7]	. Analysis of clinical characteristics and causative genes of Hutchinson-Gilford progeria syndrome in a family [J]. Chinese Journal of Dermatology, 2015, 48(3): 184-186.
[8]	. etection of macrophage migration inhibition factor and tumor necrosis factor-α in the sera of patients with vitiligo [J]. Chinese Journal of Dermatology, 2012, 45(9): 673-674.

Livedoid vasculitis: an update

PDF

Like

Knowledge

Abstract

Cite this article

share this article

References ［24］

Related Articles 8

Metrics

Comments

Recommended 10